期刊文献+

血清IL-17在结直肠癌中的表达及临床意义 被引量:2

The expression and clinical significance of serum IL-17 in colorectal cancer
下载PDF
导出
摘要 目的研究血清IL-17在结直肠癌患者术前、术后1d及术后7d不同时段中的表达水平及其临床意义。方法应用双抗体夹心ABC-ELISA法检测20例健康志愿者(对照组)和55例结直肠癌患者术前(A组)、术后1d(B组)、术后7d(C组)血清中的IL-17浓度,分析其与结直肠癌临床病理特征的关系和术前、术后不同时段的变化。结果 A组、B组血清IL-17表达水平明显高于对照组(P〈0.05),C组血清IL-17浓度高于对照组,但差异无统计学意义(P〉0.05)。C组血清IL-17表达水平明显低于A组与B组(P〈0.05),B组血清IL-17浓度高于A组,但差异无统计学意义(P〉0.05)。IL-17的表达水平与肿瘤浸润深度、肿瘤分化程度、TNM分期、有无肿瘤神经束侵犯有关(P〈0.05),T4b患者IL-17浓度明显高于T1~3、T4a患者(P〈0.05),低分化患者IL-17浓度明显高于中、高分化患者(P〈0.05),Ⅲ期患者血清IL-17浓度明显高于Ⅰ~Ⅱ期患者(P〈0.05),有肿瘤神经束侵犯患者IL-17浓度明显高于无侵犯患者(P〈0.05)。IL-17表达水平与患者性别、年龄、肿瘤大小、肿瘤部位及脉管有无侵犯等因素无关(P〉0.05)。结论 IL-17在结直肠癌患者血清中高表达,与肿瘤浸润深度、肿瘤分化程度、TNM分期有关,其可能在结直肠癌的发生、发展中起重要的作用。 Objective To study the expression level and clinical significance of serum IL-17 in colorectal cancer patients at different time:before surgery, 1 day and 7 days after operation. Methods Detected the concentration of serum IL-17 of 20 healthy volunteers(the control group) and 55 cases of colorectal cancer patients at pre-operative(group A), 1 day after operation(group B), 7 days after operation(group C) by double antibody sandwich ABC-ELISA, and analyzed the relationship between IL-17 and clinical pathological characteristics of colorectal cancer, the preoperative and postoperative changes at different time. Results The expression level of serum IL-17 of patients in group A and group B was significantly higher than the control group(P〈0.05), and the concentration of serum IL-17 of group C was also higher than that of the control group, but there was no statistically significant difference(P〈0.05). The expression level of serum IL-17 of group C was obviously lower than that of group A and group B(P〈0.05),while the concentration of serum IL-17 of group B was higher than that of group A, which had no statistically significant difference(P〈0.05). The expression level of IL-17 was associated with infiltration depth of tumor, differentiation degree of tumor, TNM stages and whether it related to nerve tract invasion or not(P〈0.05), and the concentration of serum IL-17 in T4b patients was significantly higher than T1~3,T4a patients(P〈0.05),and it was also significantly higher in the patients with low differentiation than the patients with moderate differentiation and high differentiation(P〈0.05), the concentration of serum IL-17 in the patients with stage Ⅲ was higher than that of patients stage Ⅰ~Ⅱ, and the concentration of patients with tumor nerve bundle invasion was significantly higher than that of patients with no invasion(P〈0.05). The expression level of IL-17 had nothing to do with such factors as patient gender, age, tumor size, tumor location, and the presence of vascular infringement(P〈0.05). Conclusion IL-17 has a high expression in the serum of colorectal cancer patients,and it is associated with tumor infiltration depth, differentiation degree of tumor, TNM stages,and it may play an important role in the occurrence and development of colorectal cancer.
出处 《中国现代医药杂志》 2014年第4期36-39,共4页 Modern Medicine Journal of China
关键词 IL-17 结直肠癌 表达 临床意义 IL-17 Colorectal cancer Expression Clinical significance
  • 相关文献

参考文献12

  • 1Siegel R, Naishadham D,Jemal A. Cancer statistics,2013. CA:A Cancer Journal for Clinicians, 2013,63 ( 1 ) : 11-30.
  • 2Trinchieri G. Cancer and inflammation:an old intuition with rapid- ly evolving new concepts. Annu Rev Immunol,2012,30:677-706.
  • 3Lubberts E.IL-17/Thl7 targeting:on the road to prevent chronic destructive arthritis[J]. Cytokine, 2008,41 (2) : 84-91.
  • 4Wang L,Yi T,Kortylewski M,et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway[J]. J Exp Med, 2009,206 ( 7 ) : 1457-1464.
  • 5Kryezek I,Wei S,Szeliga W,et al. Endogenous IL-17 contributes to reduced tumor growth and metastasis [J]. Blood, 2009,114 (2) : 357-359.
  • 6X. O. Yang,A. D. Panopoulos,R. Nurieva,et al. STAT3 regulates eytokine-mediated generation of inflammatory helper T ceils. The Journal of Biological Chemistry,2007,282(13) :9358-9363.
  • 7H. Raifer,A. J. Mahiny,N. Bollig,et al. Unlike αβT eells,γδ T cells,LTi cells and NKT cells do not require IRF4 for the pro- duction of IL-17A and IL-22. European Journal of Immunology, 2012,42(12) :3189-3201.
  • 8I. Sobhani ,J. Tap,F. Roudot-Thoraval,et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE,2011,6 ( 1 ) : 16393.
  • 9C. Ma,X. Dong. Coloreetal cancer-derived Foxp3+IL-17+T cells suppress tumour-specifie CD8+ T cells. Scandinavian Journal of Immunology, 2011,74 ( 1 ) : 47-51.
  • 10温玉婷,刘伟,杨爱军,王晨昱,李敏,王金穗.IL-17和STAT3在结直肠癌组织中的表达及临床意义[J].第三军医大学学报,2011,33(17):1812-1815. 被引量:14

二级参考文献20

  • 1Bao-He Zhu, Wen-Hua Zhan, Zheng-Rong Li, Zhao Wang, Yu-Long He, Jun-Sheng Peng, Shi-Rong Cai, Jin-Ping Ma, Chang-Hua Zhang, Department of Gastrointestinal & Pancreatic Surgery, First Affiliated Hospital, Sun Yat-Sen University,Gastric Center of Sun Yat-Sen University, Guangzhou 510080, Guangdong Province, China.(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis[J].World Journal of Gastroenterology,2007,13(8):1162-1169. 被引量:30
  • 2Benchetrit F, Ciree A, Vires V, et al. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism [ J ]. Blood, 2002, 99(6) : 2114 -2121.
  • 3Lockhart E, Green A M, Flynn J L. IL-17 production is dominated by gammadeha T cells rather than CD4 T cells during Mycobacterium tuberculosis infection[J]. J Immunol, 2006, 177(7) : 4662 -4669.
  • 4Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer[J]. Front Immunol, 2012, 3:107-116.
  • 5Fanfini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets, 2008, 9(5):375-380.
  • 6Guo O Shen S, Li X, et al. Inflammatory factors promote the devel- opment of colorectal cancer[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011.36(7/:646-649.
  • 7Inozume T, Hanada K, Wang QJ, et al. IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer ceUs[J].J Immunother, 2009, 32(2):109-117.
  • 8Lyakh L, Trinchieri G, Provezza L, et al. Regulation of interleukin-12/ interleukin-23 production and the T-helper 17 response in humans Ill. Immunol Rev, 2008, 226:112-131.
  • 9Maniati E, Soper R, Hagemann T. Up for Mischief?. IL-17fI'hl7 in the tumotlr microenvironment[J]. Oncogene, 2010, 29(42):5653-5662.
  • 10Le Gouvello S, Bastuji-Garin S, Aloulou N, et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas[J]. Gut, 2008, 57(6):772-779.

共引文献27

同被引文献35

  • 1王东辉,李冬梅,马洪喜.不同类型音乐对结肠癌术后患者血清IL-6、IL-8、TNF-α及T淋巴细胞亚群的影响[J].中国老年学杂志,2014,34(9):2329-2331. 被引量:8
  • 2Mcallister F,Housseau F,Sears CL.Microbiota and im- mune responses in colon cancer: more to learn[J].Cancer J,2014,20(3):232-236.
  • 3Omrane I,Marrakchi R,Baroudi O,et al.Significant asso- ciation between interleukin-17A polymorphism and color- ectal cancer[J].Tumour Biol,2014 ,35(7): 6627-6632.
  • 4Yun JA, Kim SH, Hong HK, et al.Loss of E-Cadherin expression is associated with a poor prognosis in stage Ⅲ colorectal cancer[J].Oncology, 2014,86(5/6): 318-328.
  • 5Sobhani I,Tap J,Roudot-Thoraval F,et al.Microbial dys- biosis in colorectal cancer(CRC)patients[J].PLoS One,2011,6(1):e16393.
  • 6Chung AS, Wu X,Zhuang G, et al.An interleukin-17-media- ted paracrine network promotes tumor resistance to anti-an- giogenic therapy[J], Nat Med,2013 ,19(9):1114-1123.
  • 7Straus DS.TNFa and IL-17 cooperatively stimulate glu- cose metabolism and growth factor production in human colorectal cancer cells[J].Mol Cancer,2013(12):78.
  • 8Kryczek I,Wei S,Szeliga W,et al.Endogenous IL-17 con- tributes to reduced tumor growth and metastasis[J]. Blood,2009,114(2):357-359.
  • 9Pohl J , Nguyen-Tat M, Pech 0,et al.Computed virtual chromoendoscopy for classification of small colorectal Ie- sions:a prospective comparative study[J].Am J Gastro- enterol, 2008 ,103(3):562-569.
  • 10韩业红,田怀杲.乳腺癌病人血清中可溶性细胞间黏附分子-1及E-选择素表达水平的临床意义[J].中国实用外科杂志,2010,30(2):137-139. 被引量:3

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部